2010
Improved HIV testing coverage after scale-up of antiretroviral therapy programs in urban Zambia: Evidence from serial hospital surveillance.
Kancheya NG, Jordan AK, Zulu IS, Chanda D, Vermund SH. Improved HIV testing coverage after scale-up of antiretroviral therapy programs in urban Zambia: Evidence from serial hospital surveillance. Medical Journal Of Zambia 2010, 37: 71-77. PMID: 23180895, PMCID: PMC3503145.Peer-Reviewed Original ResearchHIV testing coverageAntiretroviral therapy programsProportion of inpatientsPost-test counselingHIV statusTherapy programUnknown statusDual rapid testSerial cross-sectional surveysRapid testHIV rapid testsHigh-prevalence settingsHospital medical wardsEssential clinical servicesTesting coverageCross-sectional surveyWard testingHIV testingMedical wardsHospital surveillanceMedical inpatientsHIV prevalencePatient dischargePrevalence settingsSeropositive status
2004
Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings
Stringer J, Sinkala M, Goldenberg RL, Kumwenda R, Acosta EP, Aldrovandi GM, Stout JP, Vermund SH. Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings. AIDS 2004, 18: 939-943. PMID: 15060442, PMCID: PMC2745979, DOI: 10.1097/00002030-200404090-00012.Peer-Reviewed Original ResearchConceptsChild HIV transmissionUnknown HIV serostatusHIV serostatusHIV transmissionPreliminary efficacyLabour wardHIV DNA polymerase chain reactionSingle-dose nevirapinePrevention of motherProspective cohort studyEvidence of infectionHigh-prevalence settingsWeeks of lifeNevirapine administrationNevirapine coverageChild transmissionCohort studyComparison cohortAdherence ratesPrevalence settingsPolymerase chain reactionCord bloodDNA polymerase chain reactionHIVInfant specimens
2001
Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV
Sinkala M, Stout J, Vermund S, Goldenberg R, Stringer J. Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV. The Lancet 2001, 358: 1611-1612. PMID: 11716891, DOI: 10.1016/s0140-6736(01)06662-4.Peer-Reviewed Original Research